Co-introduction of a steroid with docetaxel chemotherapy for metastatic castration-resistant prostate cancer affects PSA flare-Reference-Cited by-同舟云学术

Co-introduction of a steroid with docetaxel chemotherapy for metastatic castration-resistant prostate cancer affects PSA flare

Published:2016-04-06 Issue:6 Volume:118 Page:880-884
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Shiota Masaki¹,Yokomizo Akira¹,Takeuchi Ario¹,Kiyoshima Keijiro¹,Inokuchi Junichi¹,Tatsugami Katsunori¹,Shiga Ken-ichiro²,Koga Hirofumi²,Yamaguchi Akito²,Naito Seiji²,Eto Masatoshi¹

Affiliation:

1. Department of Urology; Graduate School of Medical Sciences; Kyushu University; Fukuoka Japan

2. Division of Urology; Harasanshin Hospital; Fukuoka Japan

Funder

Japan Society for the Promotion of Science London

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13483/fullpdf

Reference17 articles.

1. Clinical significance of a prostate-specific antigen flare phenomenon in patients with hormone-refractory prostate cancer receiving docetaxel;Olbert;Anticancer Drugs,2006

2. Prostate-specific antigen flare phenomenon with docetaxel-based chemotherapy in patients with androgen-independent prostate cancer;Sella;BJU Int,2008

3. Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy;Nelius;Int Urol Nephrol,2008

4. The postchemotherapy PSA surge syndrome;Thuret;Ann Oncol,2008

5. The oncological outcomes and risk stratification in docetaxel chemotherapy for castration-resistant prostate cancer;Shiota;Jpn J Clin Oncol,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and Prognostic Implications of PSA Flares during Radium-223 Treatment among Men with Metastatic Castration Resistant Prostate Cancer;Journal of Clinical Medicine;2023-08-28

2. Prognostic significance of risk stratification in CHAARTED and LATITUDE studies among Japanese men with castration-resistant prostate cancer;Prostate International;2022-03

3. Anticancer Effect of Second-line Treatment for Castration-Resistant Prostate Cancer Following First-line Treatment with Androgen Receptor Pathway Inhibitors;JMA Journal;2022

4. Predictive factors of survival outcomes in first‐line therapy for metastatic castration‐resistant prostate cancer;International Journal of Urology;2021-09-22

5. Differential prognostic impact of complete blood count-related parameters by prior use of novel androgen receptor pathway inhibitors in docetaxel-treated castration-resistant prostate cancer patients;Anti-Cancer Drugs;2021-08-11